CAMIDANLUMAB

Approval Year

Name

Type

Language

CAMIDANLUMAB

Official Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 2 RECEPTOR .ALPHA. CHAIN)(HUMAN HUMAX-TAC HEAVY CHAIN), DISULFIDE WITH HUMAN HUMAX-TAC LIGHT CHAIN, DIMER

Systematic Name

English

camidanlumab [INN]

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS INTERLEUKIN-2 RECEPTOR SUBUNIT ALPHA (TAC ANTIGEN, P55, CD25 ANTIGEN)), HOMO SAPIENS MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-445) (HOMO SAPIENS VH (IGHV1-69*02 (95%) (IGHD)-IGHJ4*01 (93%)) (8.8.8) (1-115) -H

Systematic Name

English

CAMIDANLUMAB [USAN]

Common Name

English

Code System Code Type Description

INN

10590

Created by admin on Sat Dec 16 17:35:32 GMT 2023 , Edited by admin on Sat Dec 16 17:35:32 GMT 2023

PRIMARY

NCI_THESAURUS

C169821

Created by admin on Sat Dec 16 17:35:32 GMT 2023 , Edited by admin on Sat Dec 16 17:35:32 GMT 2023

PRIMARY

FDA UNII

UP9K666A04

Created by admin on Sat Dec 16 17:35:32 GMT 2023 , Edited by admin on Sat Dec 16 17:35:32 GMT 2023

PRIMARY

CAS

921618-45-3

Created by admin on Sat Dec 16 17:35:32 GMT 2023 , Edited by admin on Sat Dec 16 17:35:32 GMT 2023

PRIMARY

ACTIVE MOIETY


					UP9K666A04

CAMIDANLUMAB